Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer
December 28, 2020 16:20 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V
December 16, 2020 08:00 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2020
November 12, 2020 16:05 ET
|
Guardion Health Sciences, Inc.
Guardion Also Provides Corporate Update SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company...
Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardion’s Proprietary Lumega-Z® Formulation Compared to AREDS-2 Formulation
October 28, 2020 08:30 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders’ Meeting
October 27, 2020 08:30 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders’ Meeting
October 27, 2020 08:30 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...
Guardion Health Sciences Announces Investigator-Initiated Clinical Trial of Lumega-Z
October 26, 2020 08:00 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Guardion Provides Update on Strategy, Business Plans and Initiatives
October 05, 2020 08:30 ET
|
Guardion Health Sciences, Inc.
Emphasis on Differentiation of Brands and Development and Integration of E-Commerce Platform Further Development of Clinically Supported Nutritional Products and Continued Expansion into...
Guardion Announces Virtual Annual Meeting of Stockholders
September 11, 2020 17:20 ET
|
Guardion Health Sciences, Inc.
Annual stockholder meeting scheduled for Thursday, October 29, 2020 San Diego, California, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc.(“Guardion” or the...
Guardion Health Sciences Product Licensee Receives Registration Approval in Malaysia for Immune Support Supplement
August 27, 2020 08:30 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) today announced that Ho Wah Genting Berhad (“HWGB”), a Malaysian company...